MissionIR's  Instablog

Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
My blog:
MissionIR Blog
  • Delcath Systems, Inc. (DCTH) Receives European Approval For Its Hemofiltration Cartridge 0 comments
    Apr 5, 2012 3:19 PM | about stocks: DCTH

    Delcath Systems is a specialty pharmaceutical and medical device company focused on oncology with an initial primary focus on liver cancer. The company's proprietary system for chemosaturation is designed to administer high dose chemotherapy and other therapeutic agents to diseased areas of the body.

    The company today announced that it has received CE Mark approval for the second generation, patent pending, hemofiltration cartridge of Delcath System's proprietary Hepatic CHEMOSAT Delivery System. CE Marking confirms that a medical device complies with various European regulations. The receipt of the CE Mark allows Delcath to market and sell its Class III medical devices in the countries of the European Economic Area (NYSE:EEA).

    With the new hemofiltration cartridge, the CHEMOSAT system carries the same broad indication as the previous generation system, permitting doctors to use the product for the percutaneous intra-arterial administration of a chemotherapeutic agent, such as melphalan hydrochloride, to the liver of any patient who needs such therapy.

    The new hemofiltration cartridge has been found to remove more than 98% of melphalan while removing significantly fewer blood platelets. In addition, Delcath believes CHEMOSAT may also help to improve the management of side effects on treated patients, which may lead to greater utilization of the company system in the future.

    For further information about Delcath Systems and its CHEMOSAT product, please visit the company's website at www.delcath.com

    Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

    Stocks: DCTH
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.